Omicron may have FDA rethinking vaccine strategy for kids under 5

Omicron may have FDA rethinking vaccine strategy for kids under 5

Ars Technica

Published

If the goal is baseline protection, we can get there with 2 doses, Gottlieb says.

Full Article